Belli, M. L., Sarnelli, A., Mezzenga, E., Cesarini, F., Caroli, P., Di Iorio, V., . . . Paganelli, G. (2020). Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of (225)Ac-PSMA (Prostate-Specific Membrane Antigen). Front Oncol.
Citación estilo ChicagoBelli, Maria Luisa, et al. "Targeted Alpha Therapy in MCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of (225)Ac-PSMA (Prostate-Specific Membrane Antigen)." Front Oncol 2020.
Cita MLABelli, Maria Luisa, et al. "Targeted Alpha Therapy in MCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of (225)Ac-PSMA (Prostate-Specific Membrane Antigen)." Front Oncol 2020.